FDA Clearance Tracker · K191454
Atellica CH Amylase_2 (AMY_2)
Last checked: Nov 20, 2026Latest source record: Jul 30, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 30, 2019
Substantially Equivalent
Time to decision
60 days
Received May 31, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K191454
- Device name
- Atellica CH Amylase_2 (AMY_2)
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Applicant location
- Newark, DE
- Received
- May 31, 2019
- Decided
- Jul 30, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Catalytic Methods, Amylase (JFJ)
- Device class
- Class II
- Regulation
- 21 CFR 862.1070
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JFJ. The earliest in FDA's data is K770750, decided Jul 5, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191454
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Siemens Healthcare Diagnostics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260674 · Decided Nov 6, 2026 · 249 days after receipt
Device type: System, Test, Vitamin D (MRG) · Laboratory Medicine & Pathology
- Atellica IM CA 19-9 II510(k)
K253528 · Decided Aug 10, 2026 · 270 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
K261364 · Decided Jul 24, 2026 · 88 days after receipt
Device type: Colorimetry, Acetaminophen (LDP) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.